The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. The company employs 17,400 full-time employees The company went IPO on 2007-06-15. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
What is the price performance of UNITED LABORATORIES INTL HLDGS stock?
The current price of UNITED LABORATORIES INTL HLDGS is $1.7, it has decreased 0% in the last trading day.
What are the primary business themes or industries for The United Laboratories International Holdings Limited?
The United Laboratories International Holdings Limited belongs to Pharmaceuticals industry and the sector is Health Care
What is The United Laboratories International Holdings Limited market cap?
The United Laboratories International Holdings Limited's current market cap is $3.3B
Is The United Laboratories International Holdings Limited a buy, sell, or hold?
According to wall street analysts, 9 analysts have made analyst ratings for The United Laboratories International Holdings Limited, including 5 strong buy, 4 buy, 4 hold, 0 sell, and 5 strong sell